Apr 19, 2021 | Press Releases
CLEARUP’S FDA DE NOVO REQUEST GRANT BREAKS NEW GROUND WITH USE OF MICROCURRENT TO PROVIDE CONGESTION RELIEF FROM COLDS, FLU, ALLERGIESSAN FRANCISCO, April 19, 2021 — It’s spring allergy season and 50 million allergy sufferers are looking for relief...
Apr 19, 2021 | Press Releases
CLEARUP’S FDA DE NOVO REQUEST GRANT BREAKS NEW GROUND WITH USE OF MICROCURRENT TO PROVIDE CONGESTION RELIEF FROM COLDS, FLU, ALLERGIESSAN FRANCISCO, April 19, 2021 — It’s spring allergy season and 50 million allergy sufferers are looking for relief...
Mar 24, 2021 | Press Releases
Helping Millions Through Bioelectronics Without MedicationSAN FRANCISCO, March 24, 2021 — Tivic Health® Systems Inc., a first-in-class developer of bioelectronics health devices, today announced that the U.S. Food and Drug Administration (FDA) has expanded...
Mar 24, 2021 | Press Releases
Helping Millions Through Bioelectronics Without MedicationSAN FRANCISCO, March 24, 2021 — Tivic Health® Systems Inc., a first-in-class developer of bioelectronics health devices, today announced that the U.S. Food and Drug Administration (FDA) has expanded...
Nov 17, 2020 | Press Releases
SAN FRANCISCO, Nov. 17, 2020 — Tivic Health® Systems Inc., today announced that Michael B. Foggs, MD, FAAAAI, DFACAAI, FCCP, and chief of allergy and immunology at Advocate Medical Group of AdvocateAuroraHealth in Chicago has joined the company’s...
Nov 17, 2020 | Press Releases
SAN FRANCISCO, Nov. 17, 2020 — Tivic Health® Systems Inc., today announced that Michael B. Foggs, MD, FAAAAI, DFACAAI, FCCP, and chief of allergy and immunology at Advocate Medical Group of AdvocateAuroraHealth in Chicago has joined the company’s...